ID   WEHI-7.2 CAT2
AC   CVCL_C7PR
SY   CAT2
DR   Wikidata; Q117704987
RX   PubMed=11289160;
RX   PubMed=12203227;
RX   PubMed=15702245;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 2279; Cat.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C198577; Mouse thymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3950 ! WEHI-7.2
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 3
//
RX   PubMed=11289160;
RA   Tome M.E., Baker A.F., Powis G., Payne C.M., Briehl M.M.;
RT   "Catalase-overexpressing thymocytes are resistant to
RT   glucocorticoid-induced apoptosis and exhibit increased net tumor
RT   growth.";
RL   Cancer Res. 61:2766-2773(2001).
//
RX   PubMed=12203227; DOI=10.1002/nbm.790;
RA   Lutz N.W., Tome M.E., Aiken N.R., Briehl M.M.;
RT   "Changes in phosphate metabolism in thymoma cells suggest mechanisms
RT   for resistance to dexamethasone-induced apoptosis. A 31P NMR
RT   spectroscopic study of cell extracts.";
RL   NMR Biomed. 15:356-366(2002).
//
RX   PubMed=15702245; DOI=10.3892/ijmm.15.3.497;
RA   Tome M.E., Briehl M.M., Lutz N.W.;
RT   "Increasing the antioxidant defense in WEHI7.2 cells results in a more
RT   tumor-like metabolic profile.";
RL   Int. J. Mol. Med. 15:497-501(2005).
//